scispace - formally typeset
Open Access

Clonal evolution in cancer

Jesse J. Salk
Reads0
Chats0
About
The article was published on 2010-01-01 and is currently open access. It has received 817 citations till now. The article focuses on the topics: Somatic evolution in cancer & Cancer.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Intra-tumour heterogeneity – going beyond genetics

TL;DR: Understanding how cancer genetics synergize with the emerging non‐genetic factors will be key for development of therapies able to tackle tumour escape and thereby improve cancer patient survival is believed to be key.
Journal ArticleDOI

A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data.

TL;DR: The Clonal Heterogeneity Analysis Tool is presented, which estimates cellular fractions for both sCNAs and mutations, and uses their distributions to inform macroscopic clonal architecture.
Journal ArticleDOI

Cancer stem cells as ‘units of selection’

TL;DR: The so‐called ‘cancer stem cells’ have the essential properties required to function as the key units of selection, particularly with respect to their proliferative potential and longevity.
Journal ArticleDOI

Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations

TL;DR: The theoretical work offers a formal basis for the development of anti-cancer therapeutic protocols that go beyond the ‘maximum-tolerated-dose paradigm’, as they may be more effective than traditional protocols at keeping the size of cancer cell populations under control while avoiding the expansion of drug tolerant clones.
References
More filters
Journal ArticleDOI

Metastatic colonization by circulating tumour cells

TL;DR: An improved understanding of the mechanistic determinants of such colonization is needed to better prevent and treat metastatic cancer.
Journal ArticleDOI

Clonal evolution in breast cancer revealed by single nucleus genome sequencing

TL;DR: The data show that aneuploid rearrangements occurred early in tumour evolution and remained highly stable as the tumour masses clonally expanded, which has important implications for the diagnosis, therapeutic treatment and evolution of chemoresistance in breast cancer.